<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00567450</url>
  </required_header>
  <id_info>
    <org_study_id>2007-002254-31</org_study_id>
    <secondary_id>EudraCT: 2007-002254-31</secondary_id>
    <secondary_id>AFFSAPS: A70388-33</secondary_id>
    <nct_id>NCT00567450</nct_id>
  </id_info>
  <brief_title>Ropivacaine Versus Ropivacaine Plus Mepivacaine for Sciatic Block</brief_title>
  <official_title>Ropivacaine 0.75% vs Ropivacaine 0.75% Plus Mepivacaine 1.5% for Subgluteal Sciatic Bloc: a Prospective Double Blind Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In loco regional anesthesia, much more than for general anesthesia, the choice of the product
      is largely left at the discretion of the practitioner. Two categories of local anesthetics
      are distinguished according to their pharmacodynamic characteristics: products with a short
      time of installation and a short duration period, and products with a longer delay of
      installation of the sensitive and motor block, but with a long-term duration. Indeed, the
      combined use of two products pharmacodynamically different seems to be of a practical
      interest.

      This study provides a comparison of the onset of action of 30 ml of ropivacaine 0.75% and
      30ml of a mixture of ropivacaïne 0.75% associated with mepivacaïne 1.5% for the subgluteal
      sciatic nerve block. This is a prospective randomized double-blind study where the main
      criterion of judgment is the time of installation of a sensitive block compatible with
      surgery in the sciatic territory nerve. Fifteen patients per group were calculated to detect
      a 50% decrease of the onset of action in the combination group with a power of 90% and alpha
      to 5%, according to a previous pilot study. The secondary endpoints are the intensity and
      time of installation of the motor block, the duration of sensitive and motor block, the total
      dose of morphine administered within 48 hours, as well as its possible side effects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time of installation of a sensitive block compatible with surgery in the sciatic territory nerve</measure>
    <time_frame>4h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>intensity and time of installation of the motor block, the duration of sensitive and motor block, the total dose of morphine administered within 48 hours, and its side effects.</measure>
    <time_frame>48h</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Subgluteal Sciatic Block</condition>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30ml of a mixture of ropivacaïne 0.75% associated with mepivacaïne 1.5%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 ml of ropivacaine 0.75%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine</intervention_name>
    <description>30ml of a mixture of ropivacaïne 0.75%</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine plus mepivacaine</intervention_name>
    <description>30ml of a mixture of ropivacaïne 0.75% associated with mepivacaïne 1.5%</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years

          -  surgery of the foot under sciatic block

        Exclusion Criteria:

          -  no indication of locoregional anesthesia

          -  polyneuropathy or any neurological disease

          -  know hypersensitivity to local anesthetics

          -  porphyria

          -  atrio-ventricular block

          -  not controlled epilepsia

          -  hypovolemia

          -  pregnancy

          -  anticoagulant treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Campana Philippe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesiology department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU d'Amiens, Pole Anesthesie Réanimation, Place Victor Pauchet</name>
      <address>
        <city>Amiens cedex</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2007</study_first_submitted>
  <study_first_submitted_qc>December 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2007</study_first_posted>
  <last_update_submitted>January 27, 2009</last_update_submitted>
  <last_update_submitted_qc>January 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof Herve Dupont</name_title>
    <organization>Anesthesiology and Critical Care Department</organization>
  </responsible_party>
  <keyword>sciatic block</keyword>
  <keyword>ropivacaine</keyword>
  <keyword>mepivacaine</keyword>
  <keyword>locoregional anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Mepivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

